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Abstract.9
OBJECTIVES: Venous pressure measurement using an intravenous catheter is the sole method for the diagnosis of venous10
hypertension in patients with chronic venous insufficiency. A noninvasive tool to quantify increased venous pressure is essential11
for studying venous pathophysiology. Aim of the study was to investigate the value of controlled compression ultrasound (CCU)12
for noninvasive assessment of venous pressure (VP) of the great saphenous vein (GSV) in healthy persons and patients with13
venous insufficiency to quantify venous hypertension.14
METHODS: An optimal visible part of the GSV directly above the ankle was marked on the skin and compressed under15
ultrasound control and pressure needed for complete compression of the vein was recorded using a pressure manometer with16
a translucent silicone membrane. Complete insufficiency of the GSV (Hach IV) was documented by duplex ultrasound by an17
independent investigator before start of the study. VP measurement was performed while normal breathing, deep inspiration and18
expiration and during a standardized Valsalva maneuver.19
RESULTS: Twenty controls and 19 patients with complete insufficiency of the GSV were included. Valsalva maneuver induced20
a slight increase in VP in controls (20.1 ± 4.5 vs 25.1 ± 6.6 mbar) but a significant higher increase in patients from 26 to 37 mbar21
(IQR 18.5–28.0 vs 31.5–43.0; p< 0.001).22
CONCLUSION: Noninvasive venous pressure measurement of the great saphenous vein using CCU is feasible and documents23
an increased pressure during Valsalva maneuver in Hach IV patients compared to healthy controls.24
Keywords: Chronic venous insufficiency, venous hypertension, noninvasive pressure measurement, compression ultrasound25
1. Introduction25
Venous hypertension is the major pathophysiologic cause of symptoms in chronic venous insufficiency26
and responsible for microangiopathy and tissue alterations finally resulting in ulcerations [3, 4, 7, 13]. The27
evaluation of the microcirculatory status is challenging and time consuming [5, 11]. The sole method for28
the quantification of venous pressure is intravasal acquisition with placing a needle in the dorsal vein of the29
foot [14]. However, this ambulatory venous pressure measurement (AVPM), which is a widely accepted30
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gold standard for the diagnosis of venous hypertension, is an invasive and sometimes painful technique.31
A non-invasive and reliable tool to measure peripheral venous pressure under different conditions would32
be of great interest for further evaluation of pathophysiological mechanisms in venous disease and for33
studying new therapeutic options.34
Venous hypertension results in capillary hypertension, which is responsible for capillary leakage leading35
to edema and inflammation. The marked microangiopathy in patients with chronic venous insufficiency36
plays a crucial role in the development of trophic skin lesions (e.g. white atrophy, hyperpigmentation) [8].37
Also in skin grafts of patients with venous ulcers, severe microcirculatory changes were described and38
were characterized by hypoxia and abnormal regeneration [1]. Novel ultrasound techniques as contrast-39
enhanced ultrasound are on the way to characterize microcirculatory damage in different applications40
[6].41
Recently, a novel ultrasound based technique for measuring venous pressure non-invasively was intro-42
duced [2]. A combination of a pressure manometer with a translucent silicone membrane was used to43
measure the pressure needed to compress the vein completely, which was controlled by ultrasound [15].44
This method was validated at the cephalic vein at the forearm with excellent correlation compared to45
invasive intravenous pressure measurement (r= 0.95) within a range up to 70 cm H2O [15]. Further stud-46
ies using compression controlled ultrasound (CCU) for central venous pressure measurement confirmed47
feasibility and reliability of this noninvasive technique [16, 17].48
We performed a prospective study to investigate the value of CCU for noninvasive assessment of venous49
pressure (VP) of the great saphenous vein (GSV) in healthy persons and patients with chronic venous50
insufficiency to quantify venous hypertension.51
2. Materials and methods52
2.1. Study design53
This prospective study was performed at the two vascular centers of the university hospitals in Zurich54
and Bruderholz. Healthy volunteers without clinical signs or symptoms of chronic venous disease and55
without history of deep vein thrombosis were recruited for the control group in study center Zurich.56
Patients with known complete incompetence of the great saphenous vein (Hach IV) were recruited in57
both study centers. Exclusion criteria were history of deep vein thrombosis or past sclerotherapy or58
phlebectomy. Complete insufficiency of the GSV (Hach IV) was documented by duplex ultrasound by59
an independent investigator before start of the study.60
The study was approved by the local ethical committees of both study centers (KEK Zurich, EK-172161
and EK beider Basel, EK 316/09). All participants gave their written informed consent. The study protocol62
was published at the Protocol Registration System ClinicalTrials.gov NCT01000909.63
2.2. Controlled compression ultrasound and venous pressure measurement64
Ultrasound imaging was performed with a high-end duplex ultrasound machine (iU22, Philips, Best,65
Netherlands) using a linear 17-5 MHz transducer. SonoCT Real-time Compound Imaging (Philips) was66
used to optimize the B-Mode images and to suppress artifacts and focus position was adapted to the depth67
of the visible vein. Controls and patients were investigated in supine position after a five minute rest in68
a temperature controlled vascular laboratory. The great saphenous vein was studied in a cross section69
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Fig. 1. Non-invasive venous pressure measurement of the great saphenous vein at the ankle using a using a pressure manometer
with a translucent silicone membrane.
B-mode image just above the medial ankle (Fig. 1). After documentation of a satisfying image the point of70
measurement was marked on the skin with a waterproof marker. Cross section vein diameter and venous71
pressure measurement was performed under four conditions: normal breathing, deep inspiration, deep72
expiration and Valsalva maneuver. The Valsalva maneuver was standardized by using a tube connected73
to a separate manometer [10]. During Valsalva maneuver a constant pressure of 30 mmHg had to be74
established by the subjects. Venous pressure measurement was performed as described elsewhere [15].75
The GSV was compressed under ultrasound control and the pressure needed for complete compression of76
the vein was recorded by a pressure manometer with a translucent silicone membrane. VP was measured77
three times for each maneuver and the mean value was used for further analysis.78
2.3. Statistics79
Statistical analysis was made by using SPSS software version 20.0 (Statistical Package for the Social80
Science, IBM Corporation, Armonk, New York, USA) and was carried out in cooperation with the Division81
of Biostatistics at the Institute for Social and Preventive Medicine of the University of Zurich. Vein82
diameters showed to be normally distributed. Comparison of vein diameter within healthy controls and83
within Hach IV patients was done by paired sample test. Using the Bonferroni-correction a significance84
(2-tailed) of p< 0.01666 was considered as significant. To compare vein diameters of healthy controls85
with Hach IV patients independent sample tests including Bonferroni-correction were used by which86
significance (2-tailed) was accepted if p< 0.0125.87
VP in the group of the healthy subjects showed to be normally distributed. To analyze the values88
between the right and the left leg and between the maneuvers an ANOVA was calculated. After proving89
that there is no significant difference between the right and the left leg in healthy subjects only pressure90
values of the right side were taken to compare with Hach IV patients. As pressure values of Hach IV91
subjects were not normally distributed data are expressed as median with interquartile ranges (IQR).92
Because VP in patients with Hach IV in both legs tend to be higher compared to patients with only one93
diseased leg, pressure values for comparison with healthy subjects were only taken from one leg per94
subject.95
To compare the increase of VP from normal breathing to Valsalva maneuver a quotient was calculated96
as follows: Quotient = (VPValsalva/VPnormalbreathing) × 100%. Comparison of VP between the groups was97
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done by non-parametric, unpaired Mann-Whitney test. An asymptotic significance (2-tailed) p< 0.05 was98
considered significant for all pressure analysis.99
3. Results100
3.1. Healthy subjects101
Twenty healthy volunteers (12 men) with a mean age of 31.0 years (range 18–64) were included. Mean102
body mass index (BMI) was 23.2 kg/m2 (range 19.5–29.0). Mean systolic/diastolic blood pressure was103
115/67 mmHg (range 95–138/55–84) and mean heart rate was 67 beats per minute (range 48–115).104
3.2. Hach IV patients105
Nineteen patients (13 men, 25 legs) with a mean age of 53.0 years (range 24–75) and mean BMI106
29.1 kg/m2 (19.4–44.6) and with complete incompetence of the GSV (Hach IV) were included in the anal-107
ysis. Mean systolic/diastolic blood pressure in this group was 137.8/83.9 mmHg (range 117–176/70–105)108
and mean heart rate was 79 beats per minute (range 51–119).109
3.3. GSV diameter in healthy subjects110
Mean diameter of the GSV was 2.6 mm (right leg) and 2.6 mm (left leg) in healthy controls at rest with a111
slight increase during deep inspiration (right leg: p= 0.185, left leg: p= 0.017; both n.s. with Bonferroni-112
correction) and expiration (right leg: p= 0.285, left leg: p= 0.034; both n.s. with Bonferroni-correction)113
and a significant increase (right and left leg: p< 0.001) during Valsalva maneuver to 2.9 mm (right) and114
2.9 mm (left) respectively (Table 1).115
Table 1
Vein diameter (VD) and venous pressure (VP) of 20 healthy controls
Healthy controls
Maneuver Right legs Left legs
n= 20 n= 20
Mean (SD) Mean (SD)
VD [mm]
Normal breathing 2.6 (0.9) 2.6 (0.9)
Maximum inspiration 2.7 (0.9) 2.7 (0.9)
Maximum expiration 2.7 (0.9) 2.7 (1.0)
Valsalva 2.9 (0.9)∗ 2.9 (1.1)∗
VP [mbar]
Normal breathing 20.1 (4.5) 21.2 (6.0)
Maximum inspiration 21.9 (5.8) 22.8 (7.2)
Maximum expiration 19.8 (5.1) 21.4 (6.3)
Valsalva 25.1 (6.6)∗ 23.3 (6.1)∗
∗P< 0.001 compared to normal breathing.
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Table 2
Vein diameter (VD) and venous pressure (VP) of 19 patients
Maneuver Patients
Hach IV legs
n= 19
Mean (SD)
VD [mm]
Normal breathing 3.8 (0.9)
Maximum inspiration 4.0 (0.9)∗
Maximum expiration 3.9 (0.8)
Valsalva 4.2 (0.9)∗∗
n= 25
Median (IQR)
VP [mbar]
Normal breathing 26 (18.5–28.0)
Maximum inspiration 30 (23.5–34.5)
Maximum expiration 24 (20.5–27.5)
Valsalva 37 (31.5–43.0)∗∗
∗p= 0.002 and ∗∗p< 0.001 compared to normal breathing.
3.4. GSV diameter in Hach IV patients116
Mean diameter of the GSV in Hach IV legs was 3.8 mm with no significant increase during deep117
expiration and a significant increase during deep inspiration (p= 0.002) to 4.0 mm and Valsalva maneuver118
(p< 0.001) to 4.2 mm (Table 2).119
3.5. Comparison between GSV Diameter in healthy subjects and Hach IV patients120
GSV diameter in Hach IV patients showed to be significantly higher in each maneuver (normal breath-121
ing, maximum inspiration, maximum expiration or Valsalva maneuver) compared to vein diameters in122
healthy subjects (p< 0.001 for each comparison).123
3.6. Venous pressure in healthy subjects124
As shown in Table 1, in healthy controls there is no change of VP during normal breathing, maximum125
inspiration and maximum expiration. However, a significant difference (p< 0.001) was found between126
normal breathing and Valsalva, but no difference (p= 0.674) between the two legs was registered (Fig. 2).127
3.7. Venous pressure in Hach IV patients128
The median and IQR of VP are displayed in Table 2. Similar to the healthy controls VP changed neither129
during normal breathing, nor after maximum inspiration and maximum expiration. VP during normal130
breathing showed a significant lower value (p< 0.001) compared to Valsalva maneuver.131
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Fig. 2. Venous pressure of the great saphenous vein in healthy controls and patients in supine position at rest and during Valsalva
maneuver.
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Fig. 3. Increase in venous pressure of the great saphenous vein during Valsalva maneuver in healthy controls and patients.
3.8. Comparison between venous pressure in healthy subjects and Hach IV patients132
As mentioned above in patients with Hach IV in both legs only pressure values of the right leg were133
included to calculate potential differences to healthy controls. Statistical analysis showed no difference134
between the affected legs for normal breathing (p= 0.974) or Valsalva (p= 0.202). The diagram of the135
quotient between PVP during normal breathing and Valsalva is displayed in Fig. 3. The median pressure136
augmentation in Hach IV patients is 61.6% with an IQR of 30.9 – 94.7% while healthy controls showed137
a median pressure augmentation of 23.7% with an IQR of 7.3 – 36.3%. Mann-Whitney test showed a138
highly significant increase (p< 0.001) of PVP values in Hach IV compared to healthy controls (Fig. 2).139
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4. Discussion140
In this study a novel non-invasive method for measuring venous pressure of the great saphenous vein141
was evaluated in healthy controls and patients with venous insufficiency. In contrast to AVPM in CCU142
there is no need for inserting an intravenous line into a dorsal foot vein. Venous pressure was investigated143
in different physiologic provocation maneuvers with reproducible and plausible pressure values. Valsalva144
maneuver induced only a slight increase in VP in healthy persons but a pronounced venous hypertension145
in insufficient veins. CCU is easy to learn and can be performed repeatedly under different conditions.146
It is therefore an ideal method to further study pathophysiology of venous hypertension without an147
invasive tool. Additional to the measurement of an elevated venous pressure, a parallel characterization148
of microcirculatory changes with contrast enhanced ultrasound may be very useful and is planned in149
ongoing studies. Venous hypertension, measured non-invasively, is a crucial but not the sole factor in150
microcirculatory damage in chronic venous insufficiency. Hemorheological parameters are known to be151
a marker of venous hypertension in patients with venous disease and independent predictors of venous152
thromboembolism [12, 18]. Elevated vein pressures may also have an influence on transplanted flap153
microcirculation [9].154
However, the study has some limitations. First, we did not compare venous pressure measurements155
with the gold standard AVPM to avoid patients’ discomfort by inserting a catheter in the dorsal foot vein.156
Our method has been validated at the cephalic vein with an excellent correlation compared to invasive157
intravenous pressure measurement [15]. Second, blinding of the study was not possible due to the fact,158
that on ultrasound enlarged veins of Hach IV patients are easily visible to the investigator. The selection159
criterion of a complete valve insufficiency of the GSV was implemented to achieve a homogenous patient160
collective with comparable vascular pathology. The relatively small number of patients and controls do161
not legitimate to establish normal or cut-off values with this method. Further investigations in our vascular162
laboratory may lead to reliable standards.163
5. Conclusion164
Noninvasive venous pressure measurement of the great saphenous vein using controlled compression165
ultrasound is feasible and documents an increased pressure during Valsalva maneuver in Hach IV patients166
compared to healthy controls. This study is the basis to further evaluate therapeutic measures for chronic167
venous insufficiency regarding their effect on venous pressure.168
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